Robert W. Baker
Impact in
- Psychiatry and Mental health top 0.2%
- Bipolar Disorder and Treatment
- Schizophrenia research and treatment
- Electroconvulsive Therapy Studies
- Biological Psychiatry top 2%
- Tryptophan and brain disorders
Papers in
-
- Bipolar Disorder and Treatment 27
- Schizophrenia research and treatment 22
- Electroconvulsive Therapy Studies 8
- Attention Deficit Hyperactivity Disorder 5
- Epilepsy research and treatment 4
- Co-authors
- Mauricio Tohen (22 shared papers)Richard C. Risser (10 shared papers)Craig R. Rush (10 shared papers)Joseph R. Calabrese (7 shared papers)Charles L. Bowden (6 shared papers)Alan Breier (7 shared papers)Carlos A. Zarate (8 shared papers)Bohdan Siryk (1 shared paper)
- Journals
- Journal of Clinical Psychopharmacology (5 papers)American Journal of Psychiatry (5 papers)European Neuropsychopharmacology (5 papers)The Journal of Clinical Psychiatry (4 papers)Experimental and Clinical Psychopharmacology (4 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Robert W. Baker
88 papers receiving 4.3k citations
Robert W. Baker's Hit Papers
Peers
Comparison fields: 5 of 145
- Psychiatry and Mental health 3.1k
- Biological Psychiatry 154
- Pharmacology 474
- Cellular and Molecular Neuroscience 362
- Clinical Psychology 395
Countries citing papers authored by Robert W. Baker
This map shows the geographic impact of Robert W. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Baker more than expected).
Fields of papers citing papers by Robert W. Baker
This network shows the impact of papers produced by Robert W. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Baker. The network helps show where Robert W. Baker may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert W. Baker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression Hit paper breakdown → | 2003 | 621 |
| 2 | 2002 | 291 | |
| 3 | 2005 | 244 | |
| 4 | 2003 | 233 | |
| 5 | 2006 | 222 | |
| 6 | 2004 | 214 | |
| 7 | 2002 | 185 | |
| 8 | 1986 | 176 | |
| 9 | 2006 | 170 | |
| 10 | 2003 | 166 | |
| 11 | 2001 | 139 | |
| 12 | 2001 | 88 | |
| 13 | 2007 | 84 | |
| 14 | 2002 | 82 | |
| 15 | 1993 | 77 | |
| 16 | 1999 | 73 | |
| 17 | 2003 | 71 | |
| 18 | 2001 | 70 | |
| 19 | 2003 | 68 | |
| 20 | 2006 | 63 |
About Robert W. Baker
Robert W. Baker is a scholar working on Psychiatry and Mental health, Clinical Psychology, Cellular and Molecular Neuroscience, Experimental and Cognitive Psychology and Aerospace Engineering, having authored 89 papers that have together received 4.6k indexed citations. Recurring topics across this work include Bipolar Disorder and Treatment (27 papers), Schizophrenia research and treatment (22 papers), Wind Energy Research and Development (8 papers), Neurotransmitter Receptor Influence on Behavior (8 papers), Electroconvulsive Therapy Studies (8 papers), Attention Deficit Hyperactivity Disorder (5 papers), Wind and Air Flow Studies (5 papers) and Epilepsy research and treatment (4 papers). The work is most often cited by research in Psychiatry and Mental health (3.1k citations), Biological Psychiatry (154 citations), Pharmacology (474 citations), Cellular and Molecular Neuroscience (362 citations) and Clinical Psychology (395 citations). Robert W. Baker has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Mauricio Tohen, Richard C. Risser, Craig R. Rush, Joseph R. Calabrese, Charles L. Bowden, Alan Breier, Carlos A. Zarate, Bohdan Siryk, Angela R. Evans and Trisha Suppes. Their work appears in journals such as Journal of Clinical Psychopharmacology, American Journal of Psychiatry, European Neuropsychopharmacology, The Journal of Clinical Psychiatry and Experimental and Clinical Psychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.